PPBT Latest Press Releases

-- June 11, 2026 --

Purple Biotech Presents New Preclinical Data at EACR 2026 Highlighting IM1240's Anti-Tumor Activity, Favorable Safety and Pharmacokinetic Profile, and Broad Therapeutic Window Globe Newswire 7:00 AM

-- May 15, 2026 --

Purple Biotech Reports First Quarter 2026 Financial Results and Business Highlights Globe Newswire 7:00 AM

-- April 27, 2026 --

Purple Biotech Announces New Data from CAPTN-3 Platform Tri-specific IM1240 Globe Newswire 7:00 AM

-- April 23, 2026 --

Purple Biotech Establishes Scientific Advisory Board to Support Development of CAPTN-3 Tri-Specific Antibody Platform Globe Newswire 7:00 AM

-- March 25, 2026 --

Purple Biotech Announces AI Collaboration with Converge Bio to Accelerate Development of its Next-Generation Tri-Specific Antibody Platform Globe Newswire 8:00 AM

-- March 17, 2026 --

Purple Biotech Regains Compliance with Nasdaq Globe Newswire 7:00 AM

-- March 13, 2026 --

Purple Biotech Announces CEO Transition Globe Newswire 8:04 AM

Purple Biotech Reports Fourth Quarter and Full Year 2025 Financial Results Globe Newswire 8:00 AM

-- February 25, 2026 --

Purple Biotech Announces Plan to Implement ADS Ratio Change Globe Newswire 4:20 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software